Company intelligence / Profile preview

Ankh Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Ankh Pharmaceuticals is a biotechnology company focused on the development of novel therapeutics targeting the biology of aging. The company leverages insights into sirtuin activation and metabolic pathways to create small molecule drugs aimed at extending healthy lifespan and treating age-related pathologies. Their research primarily centers on sirtuin modulators that can potentially address a broad range of conditions, including neurodegeneration and metabolic dysfunction. Ankh Pharmaceuticals aims to translate longevity science into clinical applications that improve human healthspan.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Drug pipeline

12 assets

Sanjeevini

Unknown

11 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Ankh Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankh Pharmaceuticals.

Explore the full profile